207 related articles for article (PubMed ID: 24218269)
21. A new mouse anti-mouse complement receptor type 2 and 1 (CR2/CR1) monoclonal antibody as a tool to study receptor involvement in chronic models of immune responses and disease.
Kulik L; Hewitt FB; Willis VC; Rodriguez R; Tomlinson S; Holers VM
Mol Immunol; 2015 Feb; 63(2):479-88. PubMed ID: 25457881
[TBL] [Abstract][Full Text] [Related]
22. Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens.
Reynes M; Aubert JP; Cohen JH; Audouin J; Tricottet V; Diebold J; Kazatchkine MD
J Immunol; 1985 Oct; 135(4):2687-94. PubMed ID: 2411809
[TBL] [Abstract][Full Text] [Related]
23. Proliferation of resting B cells is modulated by CR2 and CR1.
Fingeroth JD; Heath ME; Ambrosino DM
Immunol Lett; 1989 Jun; 21(4):291-301. PubMed ID: 2527816
[TBL] [Abstract][Full Text] [Related]
24. Histochemical contributions to the binding mechanism of complement (CR1, CR2) receptors.
Baranyay F
Pathol Oncol Res; 2009 Dec; 15(4):639-44. PubMed ID: 19353305
[TBL] [Abstract][Full Text] [Related]
25. Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex.
Tuveson DA; Ahearn JM; Matsumoto AK; Fearon DT
J Exp Med; 1991 May; 173(5):1083-9. PubMed ID: 1708808
[TBL] [Abstract][Full Text] [Related]
26. Murine macrophages lack expression of the Cr2-145 (CR2) and Cr2-190 (CR1) gene products.
Martin BK; Weis JH
Eur J Immunol; 1993 Nov; 23(11):3037-42. PubMed ID: 7693486
[TBL] [Abstract][Full Text] [Related]
27. Ontogeny of the follicular dendritic cell phenotype and function in the postnatal murine spleen.
Balogh P; Aydar Y; Tew JG; Szakal AK
Cell Immunol; 2001 Nov; 214(1):45-53. PubMed ID: 11902828
[TBL] [Abstract][Full Text] [Related]
28. A Novel Image Analysis Approach Reveals a Role for Complement Receptors 1 and 2 in Follicular Dendritic Cell Organization in Germinal Centers.
Anania JC; Westin A; Adler J; Heyman B
Front Immunol; 2021; 12():655753. PubMed ID: 33912182
[TBL] [Abstract][Full Text] [Related]
29. Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2.
Chen Z; Koralov SB; Kelsoe G
J Exp Med; 2000 Nov; 192(9):1339-52. PubMed ID: 11067882
[TBL] [Abstract][Full Text] [Related]
30. Optimal germinal center B cell activation and T-dependent antibody responses require expression of the mouse complement receptor Cr1.
Donius LR; Handy JM; Weis JJ; Weis JH
J Immunol; 2013 Jul; 191(1):434-47. PubMed ID: 23733878
[TBL] [Abstract][Full Text] [Related]
31. Structure and signalling functions of C3 receptors on human B cells.
Frade R
Semin Immunol; 1990 Mar; 2(2):159-64. PubMed ID: 2151800
[TBL] [Abstract][Full Text] [Related]
32. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus.
Wilson JG; Ratnoff WD; Schur PH; Fearon DT
Arthritis Rheum; 1986 Jun; 29(6):739-47. PubMed ID: 2941021
[TBL] [Abstract][Full Text] [Related]
33. Interaction of iC3b with recombinant isotypic and chimeric forms of CR2.
Kalli KR; Ahearn JM; Fearon DT
J Immunol; 1991 Jul; 147(2):590-4. PubMed ID: 1830068
[TBL] [Abstract][Full Text] [Related]
34. Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2.
Molina H; Kinoshita T; Webster CB; Holers VM
J Immunol; 1994 Jul; 153(2):789-95. PubMed ID: 8021513
[TBL] [Abstract][Full Text] [Related]
35. CR2 is the primary acceptor site for C3 during alternative pathway activation of complement on human peripheral B lymphocytes.
Marquart HV; Svehag SE; Leslie RG
J Immunol; 1994 Jul; 153(1):307-15. PubMed ID: 7515925
[TBL] [Abstract][Full Text] [Related]
36. The influence of complement receptor type 1 (CD35) and decay-accelerating factor (CD55) on complement receptor type 2- (CD21) mediated alternative pathway activation by B cells.
Leslie RG
Immunology; 1999 Jul; 97(3):371-3. PubMed ID: 10447756
[TBL] [Abstract][Full Text] [Related]
37. B cell complement receptor 2 transfer reaction.
Lindorfer MA; Jinivizian HB; Foley PL; Kennedy AD; Solga MD; Taylor RP
J Immunol; 2003 Apr; 170(7):3671-8. PubMed ID: 12646632
[TBL] [Abstract][Full Text] [Related]
38. Ligand specificities of mouse complement receptor types 1 (CR1) and 2 (CR2) purified from spleen cells.
Pramoonjago P; Takeda J; Kim YU; Inoue K; Kinoshita T
Int Immunol; 1993 Apr; 5(4):337-43. PubMed ID: 7684250
[TBL] [Abstract][Full Text] [Related]
39. Deficiencies of human C3 complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21).
Kazatchkine MD; Fearon DT
Immunodefic Rev; 1990; 2(1):17-41. PubMed ID: 2164822
[TBL] [Abstract][Full Text] [Related]
40. Co-ligation of mouse complement receptors 1 and 2 with surface IgM rescues splenic B cells and WEHI-231 cells from anti-surface IgM-induced apoptosis.
Kozono Y; Duke RC; Schleicher MS; Holers VM
Eur J Immunol; 1995 Apr; 25(4):1013-7. PubMed ID: 7737272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
